FDA Panel Votes to Remove Long-Used Osteoporosis Drug Over Cancer Risk

A panel of federal health experts says a long-established bone strengthening drug should no longer be used by women because there is little evidence it works and it may actually increase the risk of cancer.

Read More

Share this article